Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005930 | axoneme | 2 | 11 |
GO:0110165 | cellular anatomical entity | 1 | 11 |
GO:0005737 | cytoplasm | 2 | 1 |
GO:0044297 | cell body | 2 | 1 |
GO:0016020 | membrane | 2 | 1 |
Related structures:
AlphaFold database: A4HK54
Term | Name | Level | Count |
---|---|---|---|
GO:0009987 | cellular process | 1 | 11 |
GO:0016043 | cellular component organization | 3 | 11 |
GO:0022607 | cellular component assembly | 4 | 11 |
GO:0036158 | outer dynein arm assembly | 7 | 11 |
GO:0036159 | inner dynein arm assembly | 7 | 11 |
GO:0043933 | protein-containing complex organization | 4 | 11 |
GO:0065003 | protein-containing complex assembly | 5 | 11 |
GO:0070286 | axonemal dynein complex assembly | 6 | 11 |
GO:0071840 | cellular component organization or biogenesis | 2 | 11 |
GO:0001539 | cilium or flagellum-dependent cell motility | 3 | 1 |
GO:0006996 | organelle organization | 4 | 1 |
GO:0030030 | cell projection organization | 4 | 1 |
GO:0030031 | cell projection assembly | 5 | 1 |
GO:0044458 | motile cilium assembly | 7 | 1 |
GO:0044782 | cilium organization | 5 | 1 |
GO:0048870 | cell motility | 2 | 1 |
GO:0060271 | cilium assembly | 6 | 1 |
GO:0060285 | cilium-dependent cell motility | 4 | 1 |
GO:0070925 | organelle assembly | 5 | 1 |
GO:0120031 | plasma membrane bounded cell projection assembly | 6 | 1 |
GO:0120036 | plasma membrane bounded cell projection organization | 5 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 11 |
GO:0044877 | protein-containing complex binding | 2 | 11 |
GO:0070840 | dynein complex binding | 3 | 11 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 524 | 528 | PF00656 | 0.541 |
CLV_C14_Caspase3-7 | 65 | 69 | PF00656 | 0.324 |
CLV_NRD_NRD_1 | 246 | 248 | PF00675 | 0.346 |
CLV_NRD_NRD_1 | 269 | 271 | PF00675 | 0.399 |
CLV_NRD_NRD_1 | 339 | 341 | PF00675 | 0.393 |
CLV_NRD_NRD_1 | 389 | 391 | PF00675 | 0.472 |
CLV_NRD_NRD_1 | 412 | 414 | PF00675 | 0.717 |
CLV_NRD_NRD_1 | 566 | 568 | PF00675 | 0.628 |
CLV_NRD_NRD_1 | 585 | 587 | PF00675 | 0.353 |
CLV_PCSK_FUR_1 | 337 | 341 | PF00082 | 0.547 |
CLV_PCSK_KEX2_1 | 246 | 248 | PF00082 | 0.364 |
CLV_PCSK_KEX2_1 | 269 | 271 | PF00082 | 0.399 |
CLV_PCSK_KEX2_1 | 294 | 296 | PF00082 | 0.526 |
CLV_PCSK_KEX2_1 | 337 | 339 | PF00082 | 0.416 |
CLV_PCSK_KEX2_1 | 389 | 391 | PF00082 | 0.502 |
CLV_PCSK_KEX2_1 | 566 | 568 | PF00082 | 0.574 |
CLV_PCSK_KEX2_1 | 585 | 587 | PF00082 | 0.603 |
CLV_PCSK_PC1ET2_1 | 294 | 296 | PF00082 | 0.526 |
CLV_PCSK_SKI1_1 | 262 | 266 | PF00082 | 0.412 |
CLV_PCSK_SKI1_1 | 33 | 37 | PF00082 | 0.296 |
CLV_PCSK_SKI1_1 | 356 | 360 | PF00082 | 0.410 |
CLV_PCSK_SKI1_1 | 535 | 539 | PF00082 | 0.721 |
CLV_Separin_Metazoa | 481 | 485 | PF03568 | 0.451 |
DEG_SPOP_SBC_1 | 170 | 174 | PF00917 | 0.626 |
DOC_CDC14_PxL_1 | 250 | 258 | PF14671 | 0.395 |
DOC_CYCLIN_yCln2_LP_2 | 510 | 516 | PF00134 | 0.472 |
DOC_MAPK_gen_1 | 243 | 253 | PF00069 | 0.393 |
DOC_MAPK_gen_1 | 316 | 325 | PF00069 | 0.475 |
DOC_MAPK_gen_1 | 337 | 348 | PF00069 | 0.455 |
DOC_MAPK_MEF2A_6 | 246 | 253 | PF00069 | 0.355 |
DOC_MAPK_MEF2A_6 | 67 | 75 | PF00069 | 0.353 |
DOC_MAPK_NFAT4_5 | 246 | 254 | PF00069 | 0.387 |
DOC_PP1_RVXF_1 | 46 | 52 | PF00149 | 0.318 |
DOC_PP2B_LxvP_1 | 251 | 254 | PF13499 | 0.403 |
DOC_USP7_MATH_1 | 158 | 162 | PF00917 | 0.690 |
DOC_USP7_MATH_1 | 226 | 230 | PF00917 | 0.347 |
DOC_USP7_MATH_1 | 429 | 433 | PF00917 | 0.467 |
DOC_USP7_MATH_1 | 444 | 448 | PF00917 | 0.539 |
DOC_WW_Pin1_4 | 464 | 469 | PF00397 | 0.698 |
DOC_WW_Pin1_4 | 525 | 530 | PF00397 | 0.485 |
LIG_14-3-3_CanoR_1 | 295 | 305 | PF00244 | 0.485 |
LIG_14-3-3_CanoR_1 | 318 | 325 | PF00244 | 0.408 |
LIG_14-3-3_CanoR_1 | 33 | 41 | PF00244 | 0.246 |
LIG_14-3-3_CanoR_1 | 535 | 543 | PF00244 | 0.527 |
LIG_14-3-3_CanoR_1 | 585 | 591 | PF00244 | 0.612 |
LIG_14-3-3_CanoR_1 | 81 | 87 | PF00244 | 0.404 |
LIG_Actin_WH2_2 | 312 | 328 | PF00022 | 0.318 |
LIG_Actin_WH2_2 | 91 | 109 | PF00022 | 0.284 |
LIG_APCC_ABBA_1 | 41 | 46 | PF00400 | 0.400 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.452 |
LIG_Clathr_ClatBox_1 | 482 | 486 | PF01394 | 0.559 |
LIG_deltaCOP1_diTrp_1 | 365 | 374 | PF00928 | 0.538 |
LIG_deltaCOP1_diTrp_1 | 574 | 582 | PF00928 | 0.547 |
LIG_FHA_1 | 193 | 199 | PF00498 | 0.541 |
LIG_FHA_1 | 297 | 303 | PF00498 | 0.472 |
LIG_FHA_1 | 3 | 9 | PF00498 | 0.363 |
LIG_FHA_1 | 318 | 324 | PF00498 | 0.578 |
LIG_FHA_1 | 426 | 432 | PF00498 | 0.603 |
LIG_FHA_1 | 459 | 465 | PF00498 | 0.696 |
LIG_FHA_1 | 85 | 91 | PF00498 | 0.334 |
LIG_FHA_2 | 125 | 131 | PF00498 | 0.446 |
LIG_FHA_2 | 141 | 147 | PF00498 | 0.237 |
LIG_FHA_2 | 172 | 178 | PF00498 | 0.484 |
LIG_FHA_2 | 255 | 261 | PF00498 | 0.434 |
LIG_LIR_Gen_1 | 146 | 154 | PF02991 | 0.353 |
LIG_LIR_Gen_1 | 42 | 52 | PF02991 | 0.310 |
LIG_LIR_Gen_1 | 574 | 584 | PF02991 | 0.600 |
LIG_LIR_Nem_3 | 146 | 152 | PF02991 | 0.395 |
LIG_LIR_Nem_3 | 42 | 47 | PF02991 | 0.336 |
LIG_LIR_Nem_3 | 574 | 579 | PF02991 | 0.556 |
LIG_LRP6_Inhibitor_1 | 75 | 81 | PF00058 | 0.404 |
LIG_NRBOX | 478 | 484 | PF00104 | 0.649 |
LIG_SH2_CRK | 19 | 23 | PF00017 | 0.355 |
LIG_SH2_STAT5 | 102 | 105 | PF00017 | 0.271 |
LIG_SH2_STAT5 | 232 | 235 | PF00017 | 0.369 |
LIG_SH2_STAT5 | 258 | 261 | PF00017 | 0.358 |
LIG_SH2_STAT5 | 44 | 47 | PF00017 | 0.311 |
LIG_SH3_3 | 205 | 211 | PF00018 | 0.689 |
LIG_SH3_3 | 260 | 266 | PF00018 | 0.386 |
LIG_SH3_3 | 465 | 471 | PF00018 | 0.707 |
LIG_SUMO_SIM_par_1 | 379 | 386 | PF11976 | 0.353 |
LIG_TRAF2_1 | 362 | 365 | PF00917 | 0.431 |
LIG_TRAF2_1 | 405 | 408 | PF00917 | 0.577 |
MOD_CK1_1 | 115 | 121 | PF00069 | 0.438 |
MOD_CK1_1 | 141 | 147 | PF00069 | 0.443 |
MOD_CK1_1 | 445 | 451 | PF00069 | 0.495 |
MOD_CK1_1 | 458 | 464 | PF00069 | 0.668 |
MOD_CK1_1 | 58 | 64 | PF00069 | 0.486 |
MOD_CK1_1 | 69 | 75 | PF00069 | 0.300 |
MOD_CK1_1 | 82 | 88 | PF00069 | 0.271 |
MOD_CK2_1 | 124 | 130 | PF00069 | 0.427 |
MOD_CK2_1 | 171 | 177 | PF00069 | 0.488 |
MOD_CK2_1 | 379 | 385 | PF00069 | 0.550 |
MOD_GlcNHglycan | 160 | 163 | PF01048 | 0.551 |
MOD_GlcNHglycan | 199 | 202 | PF01048 | 0.747 |
MOD_GlcNHglycan | 420 | 423 | PF01048 | 0.725 |
MOD_GlcNHglycan | 447 | 450 | PF01048 | 0.721 |
MOD_GlcNHglycan | 506 | 509 | PF01048 | 0.501 |
MOD_GlcNHglycan | 514 | 517 | PF01048 | 0.587 |
MOD_GlcNHglycan | 521 | 524 | PF01048 | 0.644 |
MOD_GlcNHglycan | 59 | 63 | PF01048 | 0.480 |
MOD_GSK3_1 | 115 | 122 | PF00069 | 0.279 |
MOD_GSK3_1 | 141 | 148 | PF00069 | 0.332 |
MOD_GSK3_1 | 165 | 172 | PF00069 | 0.610 |
MOD_GSK3_1 | 296 | 303 | PF00069 | 0.524 |
MOD_GSK3_1 | 379 | 386 | PF00069 | 0.353 |
MOD_GSK3_1 | 425 | 432 | PF00069 | 0.577 |
MOD_GSK3_1 | 445 | 452 | PF00069 | 0.528 |
MOD_GSK3_1 | 519 | 526 | PF00069 | 0.670 |
MOD_GSK3_1 | 531 | 538 | PF00069 | 0.633 |
MOD_GSK3_1 | 58 | 65 | PF00069 | 0.446 |
MOD_GSK3_1 | 81 | 88 | PF00069 | 0.307 |
MOD_LATS_1 | 31 | 37 | PF00433 | 0.349 |
MOD_N-GLC_1 | 96 | 101 | PF02516 | 0.314 |
MOD_NEK2_1 | 119 | 124 | PF00069 | 0.302 |
MOD_NEK2_1 | 138 | 143 | PF00069 | 0.248 |
MOD_NEK2_1 | 178 | 183 | PF00069 | 0.503 |
MOD_NEK2_1 | 4 | 9 | PF00069 | 0.261 |
MOD_NEK2_1 | 451 | 456 | PF00069 | 0.734 |
MOD_NEK2_1 | 79 | 84 | PF00069 | 0.379 |
MOD_NEK2_1 | 86 | 91 | PF00069 | 0.298 |
MOD_NEK2_1 | 96 | 101 | PF00069 | 0.180 |
MOD_NEK2_2 | 102 | 107 | PF00069 | 0.404 |
MOD_PIKK_1 | 296 | 302 | PF00454 | 0.407 |
MOD_PIKK_1 | 317 | 323 | PF00454 | 0.519 |
MOD_PIKK_1 | 585 | 591 | PF00454 | 0.704 |
MOD_PIKK_1 | 62 | 68 | PF00454 | 0.426 |
MOD_PK_1 | 379 | 385 | PF00069 | 0.353 |
MOD_PKA_1 | 566 | 572 | PF00069 | 0.555 |
MOD_PKA_1 | 585 | 591 | PF00069 | 0.585 |
MOD_PKA_2 | 317 | 323 | PF00069 | 0.483 |
MOD_PKA_2 | 539 | 545 | PF00069 | 0.606 |
MOD_PKA_2 | 554 | 560 | PF00069 | 0.594 |
MOD_PKA_2 | 565 | 571 | PF00069 | 0.588 |
MOD_PKA_2 | 584 | 590 | PF00069 | 0.486 |
MOD_Plk_1 | 145 | 151 | PF00069 | 0.350 |
MOD_Plk_1 | 538 | 544 | PF00069 | 0.548 |
MOD_Plk_4 | 203 | 209 | PF00069 | 0.565 |
MOD_Plk_4 | 226 | 232 | PF00069 | 0.334 |
MOD_Plk_4 | 254 | 260 | PF00069 | 0.396 |
MOD_Plk_4 | 300 | 306 | PF00069 | 0.520 |
MOD_Plk_4 | 4 | 10 | PF00069 | 0.260 |
MOD_Plk_4 | 66 | 72 | PF00069 | 0.283 |
MOD_ProDKin_1 | 464 | 470 | PF00069 | 0.712 |
MOD_ProDKin_1 | 525 | 531 | PF00069 | 0.486 |
MOD_SUMO_rev_2 | 286 | 296 | PF00179 | 0.529 |
MOD_SUMO_rev_2 | 408 | 415 | PF00179 | 0.668 |
MOD_SUMO_rev_2 | 42 | 50 | PF00179 | 0.463 |
MOD_SUMO_rev_2 | 577 | 584 | PF00179 | 0.440 |
TRG_DiLeu_BaEn_1 | 376 | 381 | PF01217 | 0.346 |
TRG_DiLeu_BaEn_4 | 133 | 139 | PF01217 | 0.468 |
TRG_ENDOCYTIC_2 | 44 | 47 | PF00928 | 0.327 |
TRG_ER_diArg_1 | 245 | 247 | PF00400 | 0.366 |
TRG_ER_diArg_1 | 269 | 271 | PF00400 | 0.429 |
TRG_ER_diArg_1 | 337 | 340 | PF00400 | 0.446 |
TRG_Pf-PMV_PEXEL_1 | 176 | 180 | PF00026 | 0.477 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P804 | Leptomonas seymouri | 58% | 98% |
A0A0S4KIJ3 | Bodo saltans | 38% | 100% |
A0A3Q8IJ31 | Leishmania donovani | 75% | 99% |
A0A3R7KFT3 | Trypanosoma rangeli | 48% | 100% |
A4I7P0 | Leishmania infantum | 75% | 99% |
D0A9U1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 49% | 100% |
E9B2J7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 77% | 99% |
Q4Q5K9 | Leishmania major | 74% | 100% |
V5D6Q2 | Trypanosoma cruzi | 49% | 100% |